Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 70,657 | 36,602 | 54,348 | 13,896 | 21,486 |
| Operating Income | -70,657 | -36,602 | -32,486 | -13,896 | -21,486 |
| Other Income | 2,319 | 1,124 | 1,010 | 17 | -222 |
| Pre-tax Income | -68,338 | -35,478 | -31,476 | -13,879 | -21,708 |
| Income Tax | 1,037 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -69,375 | -35,478 | -31,476 | -13,879 | -21,708 |
| Net Income | $-69,375 | $-35,478 | $-31,476 | $-13,879 | $-21,708 |
| EPS Basic Total Ops | -4.71 | -12.17 | -24.92 | -20.00 | -38.75 |
| EPS Basic Continuous Ops | -4.71 | -12.17 | -24.92 | -19.96 | -38.85 |
| EPS Diluted Total Ops | -4.71 | -12.17 | -24.92 | -20.00 | -38.75 |
| EPS Diluted Continuous Ops | -4.71 | -12.17 | -24.92 | -19.96 | -38.85 |
| EPS Diluted Before Non-Recurring Items | -4.71 | -12.17 | -25.00 | -20.00 | -38.75 |
| EBITDA(a) | $-70,830 | $-36,721 | $-54,339 | $-13,896 | $-21,450 |